These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31328403)

  • 1. Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-β pathway.
    Chung AK; OuYang CN; Liu H; Chao M; Luo JD; Lee CY; Lu YJ; Chung IC; Chen LC; Wu SM; Tsang NM; Chang KP; Hsu CL; Li HP; Chang YS
    Cancer Med; 2019 Sep; 8(11):5116-5127. PubMed ID: 31328403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.
    Li J; Wang W; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Yi M; Xiang B
    Cancer Lett; 2019 Feb; 442():1-14. PubMed ID: 30392786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
    Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
    Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
    Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
    Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-? regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma.
    Du M; Chen W; Zhang W; Tian XK; Wang T; Wu J; Gu J; Zhang N; Lu ZW; Qian LX; Fei Q; Wang Y; Peng F; He X; Yin L
    Biomed Pharmacother; 2018 Mar; 99():688-696. PubMed ID: 29710466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and Orthotopic Murine Models of Nasopharyngeal Carcinoma Reveal Molecular Mechanisms Underlying its Malignant Progression.
    Wan X; Liu Y; Peng Y; Wang J; Yan SM; Zhang L; Wu W; Zhao L; Chen X; Ren K; Long H; Luo Y; Yan Q; Zhang L; Lei D; Liu P; Li S; Liu L; Guo L; Du J; Zhang M; Dai S; Yang Y; Liu H; Chen N; Bei J; Feng L; Liu Y; Zeng MS; Chen C; Zhong Q
    Adv Sci (Weinh); 2024 Sep; 11(36):e2403161. PubMed ID: 39049720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of PI3K-Akt/mTOR/AMPK signaling pathway genetic mutation with efficacy and prognosis in nasopharyngeal carcinoma.
    Chen Y; He Q; Ma H; Zhang L; Liu F; Han Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):165-173. PubMed ID: 35545406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
    Hsu CL; Lui KW; Chi LM; Kuo YC; Chao YK; Yeh CN; Lee LY; Huang Y; Lin TL; Huang MY; Lai YR; Yeh YM; Fan HC; Lin AC; Lu YJ; Hsieh CH; Chang KP; Tsang NM; Wang HM; Chang AY; Chang YS; Li HP
    J Exp Clin Cancer Res; 2018 Sep; 37(1):233. PubMed ID: 30236142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of a molecular classifier derived from whole-exome sequencing in nasopharyngeal carcinoma.
    Wang HY; Li F; Liu N; Liu XY; Yang XH; Guo YM; Bei JX; Zeng YX; Shao JY
    Cancer Med; 2019 Jun; 8(6):2705-2716. PubMed ID: 30950204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma.
    Zou G; Ren B; Liu Y; Fu Y; Chen P; Li X; Luo S; He J; Gao G; Zeng Z; Xiong W; Li G; Huang Y; Xu K; Zhang W
    Cancer Sci; 2018 Nov; 109(11):3416-3427. PubMed ID: 30151927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape.
    Bruce JP; To KF; Lui VWY; Chung GTY; Chan YY; Tsang CM; Yip KY; Ma BBY; Woo JKS; Hui EP; Mak MKF; Lee SD; Chow C; Velapasamy S; Or YYY; Siu PK; El Ghamrasni S; Prokopec S; Wu M; Kwan JSH; Liu Y; Chan JYK; van Hasselt CA; Young LS; Dawson CW; Paterson IC; Yap LF; Tsao SW; Liu FF; Chan ATC; Pugh TJ; Lo KW
    Nat Commun; 2021 Jul; 12(1):4193. PubMed ID: 34234122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg J; van de Loo RJM; de Jong R; Moelans CB; de Bree R; de Herdt MJ; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
    Head Neck; 2018 Sep; 40(9):1986-1998. PubMed ID: 29927011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?
    Yi M; Cai J; Li J; Chen S; Zeng Z; Peng Q; Ban Y; Zhou Y; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Aug; 233(8):5537-5549. PubMed ID: 29266238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays.
    Zhang W; Zeng Z; Fan S; Wang J; Yang J; Zhou Y; Li X; Huang D; Liang F; Wu M; Tang K; Cao L; Li X; Xiong W; Li G
    J Mol Histol; 2012 Jun; 43(3):297-306. PubMed ID: 22391627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biomarkers of nasopharyngeal carcinoma metastasis risk identified by reverse phase protein array based tumor profiling with consideration of plasma Epstein-Barr virus DNA load.
    Xu T; Su B; Huang P; Wei W; Deng Y; Sehgal V; Wang D; Jiang J; Zhang G; Li A; Yang H; Claret FX
    Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 27883284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
    Qiu W; Schönleben F; Li X; Su GH
    Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.